The Adrenal Gland in the Center

T. Chavakis; M. Ehrhart-Bornstein

doi:10.1055/s-0032-1331224

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 2013; 45(02): 79-80
DOI: 10.1055/s-0032-1331224

Editorial

The Adrenal Gland in the Center

Authors

T. Chavakis

¹Division of Vascular Inflammation, Diabetes and Kidney, University Clinic Dresden, Dresden, Germany
M. Ehrhart-Bornstein

²Division of Molecular Endocrinology, Department of Internal Medicine III, University Clinic Carl-Gustav Carus, University of Dresden, Dresden, Germany

Abstract

Full Text

References

References
1 Dringenberg T, Schwitalla M, Haase M, Scherbaum WA, Willenberg HS. Control of CYP11B2/CYP11B1 expression ratio and consequences for the zonation of the adrenal cortex. Horm Metab Res 2013; 45: 81-85
2 Chavakis T, Kanczkowski W, Willenberg HS, Bornstein SR. Endothelial dysfunction: a critical determinant in inflammation-associated adrenal insufficiency?. Eur J Clin Invest 2011; 41: 917-919
3 Kamrath C, Hartmann MF, Wudy SA. Androgen synthesis in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Metab Res 2013; 45: 86-91
4 Meyer G, Hackemann A, Penna-Martinez M, Badenhoop K. What affects quality of life in autoimmune Addison’s disease?. Horm Metab Res 2013; 45: 92-95
5 Langenheim J, Ventz M, Hinz A, Quinkler M. Modified-release prednisone decreases complaints and fatigue compared to standard prednisolone in patients with adrenal insufficiency. Horm Metab Res 2013; 45: 96-101
6 Koehler K, End K, Kind B, Landgraf D, Mitzscherling P, Huebner A. Changes in differential gene expression in fibroblast cells from patients with triple A syndrome under oxidative stress. Horm Metab Res 2013; 45: 102-108
7 Juszczak A, Ertorer ME, Grossman A. The therapy of Cushing’s disease in adults and children: an update. Horm Metab Res 2013; 45: 109-117
8 Deutschbein T, Petersenn S. Screening for Cushing’s syndrome: new immunoassays require adequate normative data. Horm Metab Res 2013; 45: 118-123
9 Lichtenauer UD, Shapiro I, Osswald A, Meurer S, Kulle A, Reincke M, Riepe F, Beuschlein F. Characterization of NCI-H295R cells as an in vitro model of hyperaldosteronism. Horm Metab Res 2013; 45: 124-129
10 Jurowich C, Fassnacht M, Kroiss M, Germer CT, Reibetanz J. Is there a role for laparoscopic adrenalectomy in patients with suspected adrenocortical carcinoma? A critical appraisal of the literature. Horm Metab Res 2013; 45: 130-136
11 Sbiera S, Kroiss M, Thamm T, Beyer M, Majidi F, Kuehner D, Wobser M, Becker JC, Adam P, Ronchi C, Allolio B, Fassnacht M. Survivin in adrenocortical tumors – pathophysiological implications and therapeutic potential. Horm Metab Res 2013; 45: 137-146
12 Matro J, Giubellino A, Pacak K. Current and future therapeutic approaches for metastatic pheochromocytoma and paraganglioma: focus on SDHB tumors. Horm Metab Res 2013; 45: 147-153
13 Prejbisz A, Lenders JW, Eisenhofer G, Januszewicz A. Mortality associated with phaeochromocytoma. Horm Metab Res 2013; 45: 154-158
14 Chung KF, Sicard F, Vukicevic V, Hermann A, Storch A, Huttner WB, Bornstein SR, Ehrhart-Bornstein M. Isolation of neural crest derived chromaffin progenitors from adult adrenal medulla. Stem Cells 2009; 27: 2602-2613
15 Santana MM, Chung KF, Vukicevic V, Rosmaninho-Salgado J, Kanczkowski W, Cortez V, Hackmann K, Bastos CA, Mota A, Schrock E, Bornstein SR, Cavadas C, Ehrhart-Bornstein M. Isolation, characterization, and differentiation of progenitor cells from human adult adrenal medulla. Stem Cells Trans Med 2012; 1: 783-791
16 Androutsellis-Theotokis A, Chrousos GP, McKay RD, Decherney AH, Kino T. Expression profiles of the nuclear receptors and their transcriptional coregulators during differentiation of neural stem cells. Horm Metab Res 2013; 45: 159-168
17 Saha S, Schwarz PE, Bergmann S, Bornstein SR, Graessler J, Kopprasch S. Circulating very-low-density lipoprotein from subjects with impaired glucose tolerance accelerates adrenocortical cortisol and aldosterone synthesis. Horm Metab Res 2013; 45: 169-172
18 Müller-Fielitz H, Raasch W. Angiotensin II impairs glucose utilization in obese Zucker rats by increasing HPA activity via an adrenal-dependent mechanism. Horm Metab Res 2013; 45: 173-180